162 related articles for article (PubMed ID: 29417588)
41. Enhanced radiosensitization with interferon-alpha-2b and cisplatin in the treatment of locally advanced cervical carcinoma.
Stock RG; Dottino P; Jennings TS; Terk M; DeWyngaert JK; Beddoe AM; Cohen C
Gynecol Oncol; 1997 Dec; 67(3):309-15. PubMed ID: 9441780
[TBL] [Abstract][Full Text] [Related]
42. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
[TBL] [Abstract][Full Text] [Related]
43. Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer.
Eifel PJ
Nat Clin Pract Oncol; 2006 May; 3(5):248-55. PubMed ID: 16683003
[TBL] [Abstract][Full Text] [Related]
44. Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus.
Chong BF; Mohan C
Expert Opin Ther Targets; 2009 Oct; 13(10):1147-53. PubMed ID: 19670960
[TBL] [Abstract][Full Text] [Related]
45. Chemoradiotherapy in the treatment of cervical cancer.
Eifel PJ
Semin Radiat Oncol; 2006 Jul; 16(3):177-85. PubMed ID: 16814159
[TBL] [Abstract][Full Text] [Related]
46. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer.
Miglietta L; Franzone P; Centurioni MG; Boni L; Tacchini L; Cosso M; Boccardo F; Ferrarini M; Bruzzone M
Oncology; 2006; 70(1):19-24. PubMed ID: 16439862
[TBL] [Abstract][Full Text] [Related]
47. The role of raltitrexed/cisplatin with concurrent radiation therapy in treating advanced cervical cancer.
Li XY; Liu L; Xie XM; Zhou C
Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3491-6. PubMed ID: 25491626
[TBL] [Abstract][Full Text] [Related]
48. Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo study.
Segovia-Mendoza M; Jurado R; Mir R; Medina LA; Prado-Garcia H; Garcia-Lopez P
BMC Cancer; 2015 Jan; 15():21. PubMed ID: 25622528
[TBL] [Abstract][Full Text] [Related]
49. [Clinical evaluation of chemoradiotherapy for advanced cervical cancer].
Kaneyasu Y; Okawa MK; Okawa T
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2084-91. PubMed ID: 9388517
[TBL] [Abstract][Full Text] [Related]
50. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer.
Chen CC; Lin JC; Jan JS; Ho SC; Wang L
Gynecol Oncol; 2011 Jul; 122(1):9-13. PubMed ID: 21514629
[TBL] [Abstract][Full Text] [Related]
51. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
52. Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study.
Muderspach LI; Curtin JP; Roman LD; Gebhardt JA; Klement V; Qian D; Morrow CP; Felix JC; Formenti SC; Muggia FM
Gynecol Oncol; 1997 May; 65(2):336-42. PubMed ID: 9159348
[TBL] [Abstract][Full Text] [Related]
53. [Cancer of the uterine cervix: combination of radiotherapy and cisplatin chemotherapy (chemoradiotherapy) is superior to radiotherapy alone in local advanced stages].
Mazeron JJ
Bull Cancer; 1999 Mar; 86(3):247-8. PubMed ID: 10847719
[No Abstract] [Full Text] [Related]
54. Inhibition of stromal CXCR4 impairs development of lung metastases.
D'Alterio C; Barbieri A; Portella L; Palma G; Polimeno M; Riccio A; Ieranò C; Franco R; Scognamiglio G; Bryce J; Luciano A; Rea D; Arra C; Scala S
Cancer Immunol Immunother; 2012 Oct; 61(10):1713-20. PubMed ID: 22399057
[TBL] [Abstract][Full Text] [Related]
55. The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma.
Wu X; Zhang H; Sui Z; Wang Y; Yu Z
Cancer Biol Med; 2021 Mar; 18(2):401-10. PubMed ID: 33710803
[TBL] [Abstract][Full Text] [Related]
56. Molecular targeted agents combined with chemo-radiation in the treatment of locally advanced cervix cancer.
Herrera FG; Vidal L; Oza A; Milosevic M; Fyles A
Rev Recent Clin Trials; 2008 May; 3(2):111-20. PubMed ID: 18474021
[TBL] [Abstract][Full Text] [Related]
57. CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model.
Domanska UM; Boer JC; Timmer-Bosscha H; van Vugt MA; Hoving HD; Kliphuis NM; Rosati S; van der Poel HG; de Jong IJ; de Vries EG; Walenkamp AM
Clin Exp Metastasis; 2014 Oct; 31(7):829-39. PubMed ID: 25154297
[TBL] [Abstract][Full Text] [Related]
58. Radiation Damage to Tumor Vasculature Initiates a Program That Promotes Tumor Recurrences.
Brown JM
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):734-744. PubMed ID: 32473180
[TBL] [Abstract][Full Text] [Related]
59. A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer.
Eksteen C; Riedemann J; Rass AM; Plessis MD; Botha MH; van der Merwe FH; Engelbrecht AM
Cancer Control; 2024; 31():10732748241261539. PubMed ID: 38881031
[TBL] [Abstract][Full Text] [Related]
60. Analysis of Curcumin as a Radiosensitizer in Cancer Therapy with Serum Survivin Examination: Randomised Control Trial.
Hidayat YM; Wagey F; Suardi D; Susanto H; Laihad BJ; Tobing MDL
Asian Pac J Cancer Prev; 2021 Jan; 22(1):139-143. PubMed ID: 33507691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
